Although it is commonly accepted that hyperglycemia is the main contributing factor to the pathogenesis of diabetic complications, studies have implicated the brain insulin resistance or defective brain insulin signaling in neurodegenerative diseases (Bassil et al., 2014). This evidence concerns the gene INS and neurodegenerative disease.